Cargando…

Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience

INTRODUCTION: Mitochondrial fatty acid oxidation disorders (FAODs) are a heterogeneous group of hereditary autosomal recessive diseases included in newborn screening (NBS) program in Italy. The aim of this study was to analyse FAODs cases, identified either clinically or by NBS,for clinical and gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Maguolo, A., Rodella, G., Dianin, A., Nurti, R., Monge, I., Rigotti, E., Cantalupo, G., Salviati, L., Tucci, S., Pellegrini, F., Molinaro, G., Lupi, F., Tonin, P., Pasini, A., Campostrini, N., Ion Popa, F., Teofoli, F., Vincenzi, M., Camilot, M., Piacentini, G., Bordugo, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414009/
https://www.ncbi.nlm.nih.gov/pubmed/32793418
http://dx.doi.org/10.1016/j.ymgmr.2020.100632
_version_ 1783568897221328896
author Maguolo, A.
Rodella, G.
Dianin, A.
Nurti, R.
Monge, I.
Rigotti, E.
Cantalupo, G.
Salviati, L.
Tucci, S.
Pellegrini, F.
Molinaro, G.
Lupi, F.
Tonin, P.
Pasini, A.
Campostrini, N.
Ion Popa, F.
Teofoli, F.
Vincenzi, M.
Camilot, M.
Piacentini, G.
Bordugo, A.
author_facet Maguolo, A.
Rodella, G.
Dianin, A.
Nurti, R.
Monge, I.
Rigotti, E.
Cantalupo, G.
Salviati, L.
Tucci, S.
Pellegrini, F.
Molinaro, G.
Lupi, F.
Tonin, P.
Pasini, A.
Campostrini, N.
Ion Popa, F.
Teofoli, F.
Vincenzi, M.
Camilot, M.
Piacentini, G.
Bordugo, A.
author_sort Maguolo, A.
collection PubMed
description INTRODUCTION: Mitochondrial fatty acid oxidation disorders (FAODs) are a heterogeneous group of hereditary autosomal recessive diseases included in newborn screening (NBS) program in Italy. The aim of this study was to analyse FAODs cases, identified either clinically or by NBS,for clinical and genetic characterization and to evaluate a five years' experience of NBS, in the attempt to figure out the complexity of genotype-phenotype correlation and to confirm the clinical impact of NBS in our centre experience. MATERIALS AND METHODS: We analysed FAODs patients diagnosed either by NBS or clinically, followed since February 2014 to April 2019 at the Regional Screening Centre and Inherited Metabolic Diseases Unit of Verona. Diagnosis was confirmed by plasma acylcarnitines, urinary organic acids, enzymatic and genetic testing. For not clear genotypes due to the presence of variants of uncertain significance, in silico predictive tools have been used as well as enzymatic activity assays. Patients underwent clinical, nutritional and biochemical follow up. RESULTS: We diagnosed 30 patients with FAODs. 20 by NBS: 3 CUD, 6 SCADD, 5 MCADD, 4 VLCADD, 2 MADD. Overall incidence of FAODs diagnosed by NBS was 1:4316 newborns. No one reported complications during the follow up period. 10 patients were diagnosed clinically: 2 CUD, 2 CPT2D, 1 VLCADD, 5 MADD. Mean age at diagnosis was 29.3 years. Within this group, complications or symptoms were reported at diagnosis, but not during follow-up. 12 mutations not previously reported in literature were found, all predicted as pathogenic or likely pathogenic. DISCUSSION AND CONCLUSIONS: Our study highlighted the great phenotypic variability and molecular heterogeneity of FAODs and confirmed the importance of a tailored follow up and treatment. Despite the short duration of follow up, early identification by NBS prevented diseases related complications and resulted in normal growth and psycho-motor development as well.
format Online
Article
Text
id pubmed-7414009
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74140092020-08-12 Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience Maguolo, A. Rodella, G. Dianin, A. Nurti, R. Monge, I. Rigotti, E. Cantalupo, G. Salviati, L. Tucci, S. Pellegrini, F. Molinaro, G. Lupi, F. Tonin, P. Pasini, A. Campostrini, N. Ion Popa, F. Teofoli, F. Vincenzi, M. Camilot, M. Piacentini, G. Bordugo, A. Mol Genet Metab Rep Research Paper INTRODUCTION: Mitochondrial fatty acid oxidation disorders (FAODs) are a heterogeneous group of hereditary autosomal recessive diseases included in newborn screening (NBS) program in Italy. The aim of this study was to analyse FAODs cases, identified either clinically or by NBS,for clinical and genetic characterization and to evaluate a five years' experience of NBS, in the attempt to figure out the complexity of genotype-phenotype correlation and to confirm the clinical impact of NBS in our centre experience. MATERIALS AND METHODS: We analysed FAODs patients diagnosed either by NBS or clinically, followed since February 2014 to April 2019 at the Regional Screening Centre and Inherited Metabolic Diseases Unit of Verona. Diagnosis was confirmed by plasma acylcarnitines, urinary organic acids, enzymatic and genetic testing. For not clear genotypes due to the presence of variants of uncertain significance, in silico predictive tools have been used as well as enzymatic activity assays. Patients underwent clinical, nutritional and biochemical follow up. RESULTS: We diagnosed 30 patients with FAODs. 20 by NBS: 3 CUD, 6 SCADD, 5 MCADD, 4 VLCADD, 2 MADD. Overall incidence of FAODs diagnosed by NBS was 1:4316 newborns. No one reported complications during the follow up period. 10 patients were diagnosed clinically: 2 CUD, 2 CPT2D, 1 VLCADD, 5 MADD. Mean age at diagnosis was 29.3 years. Within this group, complications or symptoms were reported at diagnosis, but not during follow-up. 12 mutations not previously reported in literature were found, all predicted as pathogenic or likely pathogenic. DISCUSSION AND CONCLUSIONS: Our study highlighted the great phenotypic variability and molecular heterogeneity of FAODs and confirmed the importance of a tailored follow up and treatment. Despite the short duration of follow up, early identification by NBS prevented diseases related complications and resulted in normal growth and psycho-motor development as well. Elsevier 2020-08-05 /pmc/articles/PMC7414009/ /pubmed/32793418 http://dx.doi.org/10.1016/j.ymgmr.2020.100632 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Maguolo, A.
Rodella, G.
Dianin, A.
Nurti, R.
Monge, I.
Rigotti, E.
Cantalupo, G.
Salviati, L.
Tucci, S.
Pellegrini, F.
Molinaro, G.
Lupi, F.
Tonin, P.
Pasini, A.
Campostrini, N.
Ion Popa, F.
Teofoli, F.
Vincenzi, M.
Camilot, M.
Piacentini, G.
Bordugo, A.
Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience
title Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience
title_full Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience
title_fullStr Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience
title_full_unstemmed Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience
title_short Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience
title_sort diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: a single centre experience
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414009/
https://www.ncbi.nlm.nih.gov/pubmed/32793418
http://dx.doi.org/10.1016/j.ymgmr.2020.100632
work_keys_str_mv AT maguoloa diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT rodellag diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT dianina diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT nurtir diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT mongei diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT rigottie diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT cantalupog diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT salviatil diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT tuccis diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT pellegrinif diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT molinarog diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT lupif diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT toninp diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT pasinia diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT campostrinin diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT ionpopaf diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT teofolif diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT vincenzim diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT camilotm diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT piacentinig diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience
AT bordugoa diagnosisgeneticcharacterizationandclinicalfollowupofmitochondrialfattyacidoxidationdisordersintheneweraofexpandednewbornscreeningasinglecentreexperience